A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

Novel approach targeting KAT2A/B with preclinical validation across multiple cancer models and tumor typesNEWTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage ...

The FDA ordered a clinical hold on Rocket Pharmaceuticals' Danon disease trial after the adverse event was first disclosed.

The findings suggest that "the heightened focus on alternative endpoints, now representing the most common primary endpoint, ...

START and OneOncology launch 3 new early-phase trial sites, expanding access to new cancer research in community oncology ...

Augustine Therapeutics has initiated subject dosing in the randomised Phase I trial of AGT-100216 for Charcot-Marie-Tooth ...

A novel triple reuptake inhibitor is efficacious and ‘clinically meaningful’ for adult attention-deficit/hyperactivity ...

Reviewing the Phase III clinical of the Ianalumab (VAY736) presented by Novartis, the Subject Expert Committee (SEC) ...

UC Davis Comprehensive Cancer Center is testing a drug called niraparib (ZEJULA), given before prostate cancer surgery.

Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, ...